AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 282: H757-H765, 2002. First published October 11, 2001; doi:10.1152/ajpheart.00246.2001
0363-6135/02 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/2/H757    most recent
00246.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oketani, N.
Right arrow Articles by Tei, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oketani, N.
Right arrow Articles by Tei, C.
Vol. 282, Issue 2, H757-H765, February 2002

Regulation of KATP channels by P2Y purinoceptors coupled to PIP2 metabolism in guinea pig ventricular cells

Naoya Oketani1, Masafumi Kakei2, Kotaro Ichinari1, Midori Okamura1, Akihiro Miyamura1, Mitsuhiro Nakazaki1, Seiki Ito2, and Chuwa Tei1

1 First Department of Internal Medicine, Faculty of Medicine, Kagoshima University, Kagoshima 890-8520; and 2 Division of Geriatric Medicine, Akita University School of Medicine, Akita 010-8543, Japan


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

We used patch-clamp techniques to elucidate the regulatory mechanisms of ATP-sensitive K+ (KATP) channels by stimulation of P2 purinoceptors in guinea pig ventricular myocytes. Extracellular ATP at 0.1 mM transiently inhibited by 90.5 ± 5.0% the whole cell KATP channel current evoked by a reduction in intracellular ATP concentration to 0.5 mM and exposure to 30 µM pinacidil. ADP and AMP (both 1 mM) also decreased the current by 42.8 ± 9.3% and 9.4 ± 4.8%, respectively, but adenosine did not, even at 10 mM. ATP-induced channel inhibition was hardly observed in the presence of 0.2 mM suramin, 0.2 mM guanosine 5'-O-(2-thiodiphosphate), or 0.1 mM compound 48/80, whereas it was not influenced by the presence of 0.1 µM staurosporine or 10 mM 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid in the pipette. In the presence of 10 µM wortmannin or the absence of ATP in the cytosol, the ATP-induced channel inhibition was irreversible. Phosphatidylinositol 4,5-bisphosphate (PIP2) at 0.1 mM in the outside-out patch pipette prevented ATP-induced channel inhibition. The half-maximal internal ATP concentrations for inhibition of channel activity determined in inside-out membrane patches were 13.8 µM in the presence and 1.12 mM in the absence of 0.1 mM ATP at the external side. It is concluded that activity of KATP channels is modulated by extracellular ATP by a mechanism involving P2Y purinoceptors coupled to GTP-binding proteins associated with reduction of the sarcolemmal PIP2 concentration via stimulation of phospholipase C.

phosphatidylinositol 4,5-bisphosphate, extracellular adenosine 5'-triphosphate; phosphatidylinositol turnover; phospholipase C


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

CARDIAC ATP-SENSITIVE K+ (KATP) channels have been suggested to play an important role in changes in electrical activity of the ischemic heart (24, 41). Openings of the channel reduce the myocardial damage induced by metabolic inhibition as a consequence of the shortening of action potential duration, which decreases Ca2+ influx, increases Ca2+ efflux, and thereby minimizes Ca2+ overload in myocytes. This concept has been widely accepted as a major pathophysiological mechanism in KATP channels since its discovery in the heart (27, 41).

Phosphatidylinositol 4,5-bisphosphate (PIP2) was recently reported to alter the ATP sensitivity of KATP channels (1, 10, 15, 30). An increase in PIP2 levels at the cytoplasmic face of the sarcolemma lowers sensitivity of the channel to ATP. PIP2 reactivates run-down KATP channels, which are brought about by exposure to high concentrations of Ca2+ (39). However, PIP2 did not reduce ATP sensitivity in KATP channels reactivated by PIP2 treatment from the run-down state (28). PIP2 treatment impaired sensitivity of KATP channels to the sulfonylurea tolbutamide (22). However, the sustained increase in cytosolic Ca2+ concentration decreased tolbutamide sensitivity of the channel, whereas PIP2 and ATP cooperatively protected the channel from the Ca2+-induced impairment of tolbutamide sensitivity in pancreatic beta -cells (21). These findings suggest that membrane PIP2 is a maintenance modulator of channel activity and sensitivity to sulfonylureas as well as ATP.

ATP acts as an extracellular signal in various types of tissues involved regulation of vascular tone, muscle contraction, pain, or neuronal communication (6). Under hypoxic or ischemic conditions, the source of extracellular ATP is reportedly parenchymal cells (31). Many biological responses to ATP are mediated via the P2 purinoceptor family, which are classified into two structurally and functionally distinct group of receptors: ligand-gated nonselective cation channels (P2X-type receptors) and GTP-binding protein (G protein)-coupled receptors linked to the phospholipase C (PLC) signaling cascade (P2Y-type receptors; Refs. 5 and 6). Binding of extracellular ATP to P2Y purinoceptors stimulates PLC to cleave PIP2 into diacylglycerol (DG) and inositol 1,4,5-trisphosphate (IP3) (2). We therefore postulated that stimulation of these pathways may change the activity of KATP channels by altering the sarcolemmal PIP2 concentration. In the present study, we attempted to clarify whether extracellular ATP modulates activity of the KATP channels, and the underlying mechanisms were explored in ventricular myocytes isolated from guinea pig hearts.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Studies were performed in single ventricular myocytes enzymatically isolated from guinea pig hearts as described previously (34). Briefly, male guinea pigs weighing 210-300 g were anesthetized with pentobarbital sodium (26 mg/kg) by peritoneal injection and were artificially ventilated. After thoracotomy, the heart was cannulated into the aorta, quickly excised, mounted on a Langendorff apparatus, and perfused at 37°C with oxygenated Tyrode solution containing (in mM) 137 NaCl, 5.4 KCl, 1.8 CaCl2, 1.5 MgCl2, 0.33 NaH2PO4, and 5.5 glucose (pH 7.4 with NaOH). The perfusate was switched to a nominally Ca2+-free oxygenated Tyrode solution (100 ml), and Ca2+-free Tyrode solution containing 0.04% collagenase (Worthington type II) was perfused for 15 min. The heart was then perfused to wash out collagenase with 100 ml of Kraftbrühe (KB) solution (18) containing (in mM) 40 KCl, 20 taurine, 50 glutamic acid, 20 KH2PO4, 3 MgCl2, 10 glucose, 0.5 EGTA, and 10 HEPES (pH 7.4 with KOH). The left ventricle was removed and cut into small pieces (~5 mm3) in KB solution and dispersed mechanically into single cells. The dispersed myocytes were stored in KB solution at 4°C for at least 1 h before use. Single ventricular myocytes were then placed in a recording chamber (500 µl), which was filled with Tyrode solution. Experiments were started after the cells had settled to the bottom of the chamber.

Patch pipettes were pulled from hard glass tubing (Sutter Instrument, Novato, CA), coated with silicon resin to reduce electrical capacitance, and fire polished immediately before use. Pipette resistances were between 2 and 3 MOmega for whole cell experiments and were ~5-10 MOmega for experiments of outside-out or inside-out membrane patches. All experiments were performed at 23-26°C.

Whole cell and single KATP channel currents were recorded from ventricular myocytes with the conventional patch-clamp technique (12). Data were recorded with an amplifier (Axopatch 200B, Axon Instruments, Foster City, CA) and stored by means of a PCM digital data recorder (RD-101T; TEAC, Tokyo, Japan). Replayed recordings were then low-pass filtered (24 dB/octave, E-3211A; NF, Tokyo, Japan) at the cut-off frequency indicated in Figs. 1, 4, 5, and 7 and digitized by pCLAMP6 or -7 software (Axon Instruments) on an IBM computer. In some experiments, on-line recordings of the whole cell current were performed.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of extracellular ATP on ATP-sensitive K+ (KATP) channel currents. A: chart recordings of the KATP channel current at the beginning of whole cell recording during voltage ramps (a). Decreasing the cytoplasmic ATP concentration through the pipette solution containing the lower ATP concentration (0.5 mM) and exposure of the cell to 30 µM pinacidil caused gradual increases in the outward current. In current tracings at point b the maximal current level reached several nanoamperes as illustrated in B. The top of the current tracings was cut in the chart recorder. ATP transiently inhibited KATP channel currents with minimal levels (c). The current was inhibited by 10 µM glibenclamide (d). Data were filtered at the cut-off frequency of 800 Hz. B: current-voltage relations for KATP channel currents (a to d) recorded at the times indicated in A are illustrated. C: the subtracted current-voltage relations of b - d and b - c are illustrated. D: concentration-response relations of %inhibition of the amplitudes of the KATP channel currents at +20 mV for extracellular ATP. Values are means ± SE of 3-10 results.

The ventricular myocytes were voltage-clamped at the holding potential of -70 mV, and voltage ramps were applied every 5 or 10 s from -100 mV to +50 mV at 75 mV/s and, subsequently, ramps to -70 mV at -120 mV/s. The current-voltage relations were calculated from the measurements at the down slope of the voltage ramps. To compare the effects of extracellular nucleotides or chemicals on the activity of KATP channels, amplitudes of KATP channel currents were measured at +20 mV. The percent inhibition of the channel current was obtained from the following equation (see Fig. 1): %inhibition = 100(Imax - Itest)/(Imax - Iglib), where Imax is the current amplitude maximally activated by reduction in the ATP concentration in the pipette to 0.5 mM and exposure to 30 µM pinacidil, a KATP channel opener; Itest is current amplitude during exposure to test solutions; and Iglib is current amplitude during exposure to 10 µM glibenclamide. The concentration-response relations of KATP channel currents for ATP concentrations were fitted by the Hill equation: %inhibition = 100/[1 + (IC50/[ATP])nH], where IC50 is the concentration for half-maximal channel inhibition, [ATP] is ATP concentration, and nH is the Hill coefficient.

Pipette solutions contained (in mM) 50 KCl, 90 aspartic acid, 1 KH2PO4, 1 MgCl2, 5 HEPES, 5 EGTA, 0.5 Na2ATP, and 0.1 GTP (pH adjusted to 7.2 with KOH). Na2ATP, Na2ADP, and adenosine were obtained from Boehringer (Mannheim, Germany). Na2GTP, suramin, and wortmannin were obtained from Nacalai (Kyoto, Japan). Compound 48/80 was obtained from Biomol (Plymouth Meeting, PA). Glibenclamide, staurosporine, pinacidil, and 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) were purchased from Sigma (St. Louis, MO). Glibenclamide was dissolved in DMSO to be stocked and used at the indicated concentration. PIP2 was dissolved in 0.1% DMSO and diluted by the pipette solution by sonication on ice for 30 min.

Values are expressed as means ± SE. Student's unpaired t-test or one-way ANOVA test was used to evaluate the difference between groups using Prism software (GraphPad Software). The time constants were obtained by fitting the data to a single exponential function with Prism software.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Inhibition of KATP channel currents by extracellular ATP. Because KATP channels are known to be independent of membrane voltage (19), the voltage ramp protocol was used to obtain current-voltage relations of KATP channels. The membrane potential was stepped to -100 mV from the holding potential of -70 mV, and voltage ramps to +50 mV and then to -70 mV were applied to evoke currents. The corresponding current traces are illustrated in Fig. 1A. The large inward current and small outward current through the inwardly rectifying K+ channel current (IK1) with a negative slope conductance were recorded at point a as shown in Fig. 1, A and B. In Fig. 1A, a gradual increase in the outward current was observed with a reduction in cytosolic ATP concentration by dialysis through the pipette solution containing 0.5 mM ATP and exposure to 30 µM pinacidil (Fig. 1A, point b). The inward current was also reduced before the increase in the outward current because amplitudes of mean IK1 have been reported to be inhibited by decreasing intracellular ATP concentration (19) and subsequently appeared to be increased in association with the increase in the outward current at point b. This small increase in the inward current may reflect activation of KATP channels. After exposure to 0.1 mM ATP, both the outward and inward currents were transiently reduced (point c). Glibenclamide, a specific blocker of KATP channels, substantially inhibited these currents at 10 µM (point d). This suggested that the current increased during the reduction in the cytosolic ATP concentration and inhibited by exposure to extracellular ATP must be that via the KATP channels (11). In Fig. 1B, the current-voltage relations obtained at the time indicated in Fig. 1A were plotted. The current-voltage relations (point a) showed a negative slope conductance with a small current level at the positive membrane potentials. These are properties of IK1 currents. The large increase in the outward current in association with the reduction in the cytoplasmic ATP levels was characterized by the increase in the current level at positive potentials with a reduced negative slope (point b). At points c and d, current-voltage relations similar to those at point a were depicted during superfusion with 0.1 mM ATP or 10 µM glibenclamide. The current-voltage relations of d subtracted from b indicated the glibenclamide-sensitive component and the difference between b and c was the extracellular ATP-inhibited currents (Fig. 1C). Because both curves showed similar relations against membrane potentials with the same reversal potential and a weak inwardly rectifying property, the current inhibited by ATP was that via the KATP channels (19). In Fig. 1D, concentration-response relations of the KATP channel currents for extracellular ATP measured at +20 mV are plotted. IC50 was calculated to be 4.2 µM.

Comparison of relative inhibitory potency of nucleotides and nucleosides on KATP channel currents. Both P1 and P2 purinoceptors were found in guinea pig atrial and ventricular myocytes (7, 8, 25, 38). Various types of nucleotides were used to test the inhibitory efficacy on the KATP channel currents elicited by exposure to 30 µM pinacidil and 0.5 mM ATP in the pipette (Fig. 2). The magnitude of the activated KATP channel current and the degree of inhibition of the negative slope were variable from cell to cell. This may have been caused by differences in cell size and in the capability of diffusion of intracellular ATP through the whole cell pipettes. Thus amplitudes of KATP channel currents were measured at +20 mV, and the percent inhibition of the current by nucleotides compared with controls are illustrated in Fig. 2D. The effectiveness of ADP and AMP on channel inhibition was less than that of ATP. ADP at 1 mM reduced the channel current by 42.8 ± 9.3% and 1 mM AMP reduced the current by 9.4 ± 4.8% (Fig. 2, A, B, and D). Adenosine had little effect on KATP channel currents, even at 10 mM (Fig. 2, C and D). P2 purinoceptors have been classified into two structurally and functionally distinct families, the P2X and P2Y types. Exposure of cells to 0.1 mM beta ,gamma -methylene ATP, a P2X-selective agonist, caused only a small reduction in the KATP channel currents with an inhibition of 28.3 ± 121% (n = 5). The order of the inhibitory efficacy on the activity of the KATP channels was therefore ATP > beta ,gamma -methylene ATP = ADP > AMP > adenosine.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 2.   Effects of various types of nucleotides and nucleosides on current-voltage relations of the KATP channel current evoked by a reduction in ATP in the pipette. The current-voltage relations in the absence (control) and presence of 1 mM ADP (A), 1 mM AMP (B), and 10 mM adenosine (C) are illustrated. In each trace, 10 µM glibenclamide was added at the end of the recordings to find the glibenclamide-sensitive amplitudes of KATP channel currents. D: %inhibition during exposure to each test solution measured at +20 mV and plotted. The 1-way ANOVA test was used to evaluate the difference between groups. (*P < 0.05; **P < 0.01). beta gamma mATP, beta ,gamma -methylene ATP.

Signaling pathway for channel inhibition by ATP. Binding of extracellular ATP to P2Y purinoceptors coupled to G protein has been reported to stimulate PLC to cleave PIP2 into DG and IP3 (2). We tested the effects of ATP in the presence of 0.2 mM suramin, which binds to P2 purinoceptors competitively with ATP (17). Suramin prevented ATP-induced channel inhibition, and the inhibition of the channel current was reduced to 14.6 ± 4.5% (n = 5; Fig. 3). Involvement of G proteins or PLC in ATP-induced KATP channel inhibition was also tested with a pipette solution containing guanosine 5'-O-(2-thiodiphosphate) (GDPbeta S; 0.2 mM), a nonhydrolyzable GDP analog (16), or compound 48/80, a PLC inhibitor (4). The inhibition of the channel current by ATP was reduced to 31.3 ± 9.9% (n = 5) by GDPbeta S and to 15.9 ± 6.4% (n = 6) by compound 48/80. These findings suggested that extracellular ATP inhibited the activity of the KATP channels via the pathway including P2Y purinoceptor, G protein, and PLC.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 3.   Effects of various types of compounds, inhibitors, or chelators of key elements in the subcellular pathway from P2Y purinoceptors on 0.1 mM ATP-induced KATP channel inhibition. The 1-way ANOVA test was used to evaluate the difference between groups. (**P < 0.01 vs. 0.1 mM ATP). GDPbeta S, guanosine 5'-O-(2-thiodiphosphate); BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid.

Effects of factors distal to PLC on KATP channels. Stimulation of P2Y purinoceptors causes cleavage of PIP2 to DG and IP3. These metabolites consequently activate protein kinase (PKC) and increase the cytosolic Ca2+ concentration (2, 6). Staurosporine is known to block the activity of PKC by direct interaction (33). In the presence of 0.1 µM staurosporine, KATP channel currents were inhibited by 0.1 mM ATP to an extent similar to the controls. Likewise, when 10 mM BAPTA, a potent Ca2+ chelator, was substituted for EGTA in the pipette solution, the inhibitory efficacy of the channels by ATP did not change. The inhibition by ATP was 79.1 ± 12.9% with staurosporine (n = 5) and 91.2 ± 6.3% with BAPTA (n = 5). These findings suggest that neither PKC nor change in cytosolic Ca2+ concentration was involved in ATP-induced KATP channel inhibition.

Effects of wortmannin or PIP2 on ATP-induced inhibition of KATP channel currents. From the findings presented above, we postulated an involvement of change in PIP2 concentration via modification of lipid metabolism in the sarcolemma on ATP-induced KATP channel inhibition. Because PIP2 is a determinant of the basal activity of KATP channels in ATP-free solution (28, 39), the reduction in the PIP2 concentration in the sarcolemma by P2Y purinoceptor stimulation may consequently decrease the activity of the KATP channels. Wortmannin, an inhibitor of phosphatidylinositol 3-kinase and -4-kinase, inhibits conversion to phosphatidylinositol 3,4,5-trisphosphate (PIP3) from PIP2 by lipid phosphorylation and the replenishment of PIP2 (37). In the presence of 10 µM wortmannin, ATP-induced inhibition of KATP channel currents was irreversible (n = 4; Fig. 4A). Because production of PIP2 is regulated by activity of lipid kinases sensitive to wortmannin, inhibition of these enzymes by wortmannin may be expected to reduce the supply of PIP2 in the sarcolemma. Under these conditions, stimulation of PLC by extracellular ATP may reduce the levels of PIP2 in the sarcolemma. Similarly, the reduction of PIP2 in the sarcolemma by stimulation of P2Y purinoceptors may have been exaggerated when cytosolic ATP levels were reduced with the pipette solution containing 0 mM ATP. The activity of the KATP channels was irreversibly inhibited by 0.1 mM ATP in the absence of intracellular ATP in outside-out membrane patches (n = 6; Fig. 4B). With 0.1 mM PIP2 in the pipette solution, the KATP channel currents were not inhibited by 0.1 mM ATP in any of the membrane patches tested (n = 5; Fig. 4C).


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 4.   Involvement of phosphatidylinositol 4,5-bisphosphate (PIP2) metabolism in ATP-induced KATP channel current inhibition. A: the whole cell KATP channel current was evoked by 30 µM pinacidil (arrow) with the pipette solution containing 0.5 mM ATP. ATP at 0.1 mM and 10 µM wortmannin was superfused during the period shown above the trace. The inhibition of the KATP channel currents was irreversible even after the washout of ATP and wortmannin. B: a single KATP channel current evoked by depleting intracellular ATP to 0 mM in the outside-out mode is illustrated. The channel inhibition by 0.1 mM ATP was also irreversible. C: outside-out patch recordings for KATP channels with the pipette solution containing 0.1 mM PIP2 are illustrated. ATP at 0.1 mM did not inhibit channel activity, but 10 µM glibenclamide did. The patch membrane potential was clamped at +20 mV in B and C, and data were filtered at the cut-off frequency of 800 Hz.

Enhanced sensitivity of KATP channels to cytosolic ATP in presence of extracellular ATP. We examined the effects of extracellular ATP on the concentration-response relations of the KATP channel currents for ATP at the cytosolic side in inside-out membrane patches (Fig. 5). The presence of 0.1 mM ATP at the extracellular side of the membrane patches rapidly reduced KATP channel activity after formation of the inside-out mode. Thus we superfused 30 µM pinacidil to increase the channel current to detect concentration-dependent channel inhibition by ATP throughout the experiments (Fig. 5, A and B). The IC50 for the channel inhibition by ATP was shifted from 1.12 mM in the controls to 13.8 µM in the presence of 100 µM ATP in the pipette. Thus the reduction of PIP2 levels in membrane patches may be brought about by stimulation of P2Y purinoceptors by ATP and may increase the ATP sensitivity of the channels. This may be the underlying mechanism of P2Y purinoceptor-stimulated KATP channel inhibition. These findings were comparable to those previously reported in cells expressed with both P2Y purinoceptors or muscarinic receptors and KATP channels (1, 40).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 5.   Shift of ATP sensitivity of KATP channels in the presence of 100 µM ATP at the outside of the membrane patches. A and B: the KATP channel currents were recorded in the absence (A) and presence (B) of 0.1 mM ATP in the pipette in inside-out membrane patches. The membrane excised from the cells was exposed to 30 µM pinacidil to evoke the channel current because channel currents would otherwise be inhibited by extracellular ATP even in the absence of intracellular ATP. The current data were filtered at 800 Hz. The baseline levels are indicated with short bars (designated 0) beside current traces. C: the concentration-response relations of KATP channel activity for ATP concentrations are illustrated. The KATP channel currents were recorded at a patch membrane potential of -60 mV with various concentrations of ATP in the internal solution, and the relative current, normalized to the current obtained in the absence of ATP, is plotted with pipette solution containing 100 µM ATP () or without ATP (open circle ). The curves were drawn according to the following equation: relative current = 1/[1 + ([ATP]/IC50)nH], where IC50 is concentration for half-maximal channel inhibition, [ATP] is ATP concentration, and nH is the Hill coefficient.

ATP-induced inhibition of KATP channel currents is dependent on cytosolic ATP concentration. In Fig. 6, intracellular ATP dependence of extracellular ATP-induced KATP channel inhibition is shown. Extracellular ATP at 0.1 mM inhibited whole cell KATP channel currents that were evoked by 30 µM pinacidil in the presence of 3 mM ATP in the pipette. The inhibitory efficacy was 35.5 ± 10.0% (n = 7), and this was less than that in the presence of 0.5 mM ATP in the pipette solution (Fig. 6B; P < 0.01). ATP-induced channel inhibition was transient as illustrated in Fig. 1A. Figure 6C shows the time course of relative amplitudes of KATP channel currents in response to extracellular ATP in the presence of intracellular ATP of 3 or 0.5 mM. The time to maximal inhibition of the KATP channel current was 245.0 ± 110.0 s in the presence of 3 mM ATP (n = 7) in the pipette and 819 ± 30.0 s at 0.5 mM ATP (n = 8; P = 0.12). The time constants for the inhibitory phase of the KATP channel amplitude were 80.1 ± 29.6 s in the presence of 0.5 mM ATP (n = 3) in the pipette and 371.4 ± 101.8 s in the presence of 3 mM ATP (n = 4; P < 0.05). In the presence of guanosine 5'-O-(3-thiotriphosphate) (GTPgamma S; 0.2 mM), a nonhydrolyzable GTP analog, in the pipette solution, ATP-induced KATP channel inhibition was irreversible despite the presence of 0.5 mM ATP at the cytosol (Fig. 7).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 6.   Dependence of ATP-induced KATP channel inhibition on intracellular ATP. A: current-voltage relations obtained in the presence of intracellular 3 mM ATP are illustrated in the absence (control) and presence of extracellular 0.1 mM ATP. To determine the amplitudes of the channel currents sensitive to glibenclamide, 10 µM glibenclamide was added at the end of the experiments. B: comparison between the findings obtained with 0.5 mM ATP and 3 mM ATP in the pipette. The currents were measured at +20 mV, and the %inhibition was plotted (Student's unpaired t-test; **P < 0.01). C: time course of the relative amplitude of KATP channel currents during exposure to extracellular 0.1 mM ATP plotted in the presence of 3 mM and 0.5 mM ATP in the pipette. Data were normalized to the amplitudes of KATP channel currents immediately before exposure to extracellular 0.1 mM ATP.



View larger version (21K):
[in this window]
[in a new window]
 
Fig. 7.   Irreversible inhibition of KATP channel current by 0.1 mM ATP in the presence of 0.2 mM guanosine 5'-O-(3-thiotriphosphate) (GTPgamma S) in the pipette. KATP channel currents were evoked by depletion of the intracellular ATP concentration to 0.5 mM and exposure to 30 µM pinacidil as indicated by an increase in the outward current amplitudes. Data were filtered at the cut-off frequency of 800 Hz.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

In the present study, we demonstrated that extracellular ATP reduced KATP channel currents because of the binding of ATP to purinoceptors. These findings revealed a significantly stronger inhibitory efficacy with ATP than with beta ,gamma -methylene ATP, and the order for blocking effectiveness, ATP > beta ,gamma -methylene ATP = ADP > AMP > adenosine, suggested that ATP-induced KATP channel inhibition was mediated by P2Y purinoceptors. Cardiac myocytes express different types of ATP receptors that consist of ligand-gated ion channels (P2X type) and that couple to PLC via heterotrimeric G proteins (P2Y type) (9). The present observations that extracellular ATP-induced KATP channel inhibition involved receptor-mediated stimulation of PLC coupled to G proteins support the idea that P2Y-type receptors are expressed in guinea pig ventricular myocytes and physiologically regulate KATP channels. Although KATP channel inhibition mediated by either P2Y purinoceptors or muscarinic receptors has been reported in cells overexpressed with KATP channels and PLC-linked receptors (1, 40), the present findings provide evidence that the breakdown of PIP2 mediates the activity of the KATP channels via PLC-linked receptors under physiological conditions.

In inside-out membrane patches, PIP2 is reportedly a regulator of KATP channels (1, 10, 15, 30). In the present study, we observed that the presence of extracellular ATP in inside-out membrane patches shifted the IC50 toward lower concentrations of ATP (Fig. 5). This suggests that the decrease in PIP2 levels in the membrane increases the sensitivity of the KATP channels to intracellular ATP and thereby reduces the activity of the channels. Ca2+ treatment of membrane patches attenuated the activity of the KATP channels (rundown of the channels), and subsequent treatment with PIP2 restored channel activity (28, 39). Rundown of KATP channel activity observed during Ca2+ treatment (28, 39) or in ATP-free solution (28) may reflect depletion of PIP2 levels in the membrane. However, the rundown of channel activity may not be simply due to depletion of PIP2 in the membrane because channel activity restored from the run-down state by PIP2 treatment did not exhibit less ATP sensitivity (28). Thus a more complicated mechanism regarding modulation of the channel gating by PIP2 may be required.

PKC or Ca2+ mobilization from the intracellular store sites may not be involved in KATP channel inhibition by ATP (Fig. 3). We observed irreversible channel inhibition in the presence of wortmannin or the absence of intracellular ATP, whereas staurosporine or BAPTA did not influence extracellular ATP-induced KATP channel inhibition (Fig. 4, A and B). The levels of PIP2 in the sarcolemma appeared to be regulated by a balance of replenishment from ATP via wortmannin-sensitive lipid kinases (37), expenditure via stimulation of PLC, and dephosphorylation by intrinsic phosphatase activity. Thus the reduction of sarcolemmal PIP2 levels by means of stimulation of P2Y purinoceptors may be a final determinant for the inhibition of activity of KATP channels. This was supported by the observation that ATP-induced channel inhibition was prevented when 0.1 mM PIP2 was present in the outside-out pipette solution. However, the possible involvement of PIP3, which may be a main mediator of KATP channels rather than PIP2 in diabetic ob/ob mice (23) or the insulinoma cell line (13), is not excluded. We did not find whole cell KATP channel current activation with PIP2 in the pipette up to 1 mM. This may be due to the following reasons. Diffusion of PIP2 through the pipette may not be adequate to activate KATP channels, which has been reported to take several hours (1), and the majority of PIP2 may be absorbed into the glass wall of the pipette (14). Likewise, injected PIP2 may be dephosphorylated by intrinsic phosphatase activity.

Extracellular ATP-induced inhibition of the KATP channels was transient (Figs. 1A and 6C) and was dependent on the concentration of ATP at the cytoplasmic side (Fig. 6B). Because ATP is a phosphate donor for lipid kinase, increased ATP levels in the cytosol may result in greater production of PIP2 levels in the sarcolemma. Observations that both the magnitude of the reduction and the inhibitory time constant of KATP channel currents on simulation of P2Y purinoceptors were dependent on the cytosolic ATP concentration may suggest that cytoplasmic levels of ATP underneath the sarcolemma may also influence the rate of the reduction of PIP2 levels in the sarcolemma. The finding that persistent inhibition of the channel currents was observed in the presence of GTPgamma S in the cytosol (Fig. 7) suggests that desensitization of the extracellular ATP-induced reduction of KATP channel currents occurred at a site proximal to stimulation of PLC. In a recent study a new insight that hydrolysis of PIP2 by PLC in the membrane accounts for a new form of desensitization in the GTP-binding protein-gated inwardly rectifying potassium channel current stimulated by acetylcholine has been demonstrated in atrial cells (20).

Takizawa et al. (32) reported that the whole cell KATP channel current was inhibited by norepinephrine. We also found that norepinephrine at a concentration of 0.1 µM inhibited the KATP channels (data not shown). Thus a similar mechanism may be involved in norepinephrine-induced KATP channel inhibition because alpha 1-adrenoceptors stimulate phosphatidylinositol metabolism (3, 35). The IC50 for ATP-induced KATP channel inhibition was 4.8 µM, which may be a physiologically relevant concentration at the extracellular space. Similar effective concentrations for extracellular ATP-induced modulation of ionic channels have been reported for the delayed-rectifier K+ current in the guinea pig heart (26) and for the Ca2+ channel current in the ferret heart (29) via P2Y purinoceptors. In the normal heart, the interstitial ATP concentration is reportedly in the nanomolar range (31), but it may be increased to micromolar levels in the ischemic heart (36). However, the overall effects of extracellular ATP on cardiac cells during ischemia remain to be determined.


    ACKNOWLEDGEMENTS

This work was supported in part by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (to M. Kakei).


    FOOTNOTES

Address for reprint requests and other correspondence: N. Oketani, First Dept. of Internal Medicine, Faculty of Medicine, Kagoshima Univ., 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan (E-mail: oketani{at}m.kufm.kagoshima-u.ac.jp).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

10.1152/ajpheart.00246.2001

Received 26 March 2001; accepted in final form 19 October 2001.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Baukrowitz, T, Schulte U, Oliver D, Herlitze S, Krauter T, Tucker SJ, Ruppersberg JP, and Fakler B. PIP2 and PIP as determinants for ATP inhibition of KATP channels. Science 282: 1141-1144, 1998.

2.   Berridge, MJ, and Irvine RF. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 312: 315-322, 1984.

3.   Billah, MM, and Michell RH. Phosphatidylinositol metabolism in rat hepatocytes stimulated by glycogenolytic hormones. Effects of angiotensin, vasopressin, adrenaline, ionophore A24187 and calcium-ion deprivation. Biochem J 182: 661-668, 1979.

4.   Bronner, C, Wiggins C, Monte D, Marki F, Capron A, Landry Y, and Franson RC. Compound 48/80 is a potent inhibitor of phospholipase C and a dual modulator of phospholipase A2 from human platelet. Biochim Biophys Acta 920: 301-305, 1987.

5.   Burnstock, G. P2 purinoceptors: historical perspective and classification. Ciba Found Symp 198: 1-34, 1996.

6.   Burnstock, G. The past, present and future of purine nucleotides as signaling molecules. Neuropharmacology 36: 1127-1139, 1997.

7.   Burnstock, G, and Meghji P. Distribution of P1- and P2-purinoceptors in the guinea-pig and frog heart. Br J Pharmacol 73: 879-885, 1981.

8.   Dorigo, PR, Gaion M, and Maragno I. Negative and positive influences exerted by purine compounds on isolated guinea-pig atria. J Auton Pharmacol 8: 191-196, 1988.

9.   Dubyak, GR, and el-Moatassim C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol Cell Physiol 265: C577-C606, 1993.

10.   Fan, Z, and Makielski JC. Anionic phospholipids activate ATP-sensitive potassium channels. J Biol Chem 272: 5388-5395, 1997.

11.   Fosset, M, De Weille JR, Green RD, Schmid-Antomarchi H, and Lazdunski M. Antidiabetic sulfonylureas control action potential properties in heart cells via high affinity receptors that are linked to ATP-dependent K+ channels. J Biol Chem 263: 7933-7936, 1988.

12.   Hamill, OP, Marty A, Neher E, Sakmann B, and Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391: 85-100, 1981.

13.   Harvey, J, McKay NG, Walker KS, Van der Kaay J, Downes CP, and Ashford ML. Essential role of phosphoinositide 3-kinase in leptin-induced KATP channel activation in the rat CRI-G1 insulinoma cell line. J Biol Chem 275: 4660-4669, 2000.

14.   Hilgemann, DW. The giant membrane patch. In: Single Channel Recording, edited by Sakmann B, and Neher E.. New York: Plenum, 1995, p. 307-327.

15.   Hilgemann, DW, and Ball R. Regulation of cardiac Na+, Ca2+ exchange and KATP potassium channels by PIP2. Science 273: 956-959, 1996.

16.   Holz, GG, IV, Rane SG, and Dunlap K. GTP-binding proteins mediate transmitter inhibition of voltage-dependent calcium channels. Nature 319: 670-672, 1986.

17.   Hoyle, CH, Knight GE, and Burnstock G. Suramin antagonises responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli. Br J Pharmacol 99: 617-621, 1990.

18.   Isenberg, G, and Klöckner U. Calcium tolerant ventricular myocytes prepared by preincubation in a "KB medium". Pflügers Arch 395: 6-18, 1982.

19.   Kakei, M, Noma A, and Shibasaki T. Properties of adenosine-triphosphate-regulated potassium channels in guinea-pig ventricular cells. J Physiol (Lond) 363: 441-462, 1985.

20.   Kobrinsky, E, Mirshahi T, Zhang H, Jin T, and Logothetis DE. Receptor-mediated hydrolysis of plasma membrane messenger PIP2 leads to K+-current desensitization. Nat Cell Biol 2: 507-514, 2000.

21.   Koriyama, N, Kakei M, Nakazaki M, Yaekura K, Ichinari K, Gong Q, Morimitsu S, Yada T, and Tei C. PIP2 and ATP cooperatively prevent cytosolic Ca2+-induced modification of ATP-sensitive K+ channels in rat pancreatic beta -cells. Diabetes 49: 1830-1839, 2000.

22.   Koster, JC, Sha Q, and Nichols CG. Sulfonylurea and K+-channel opener sensitivity of KATP channels, functional coupling of Kir6.2 and SUR1 subunits. J Gen Physiol 114: 203-213, 1999.

23.   Larsson, O, Barker CJ, and Berggren PO. Phosphatidylinositol 4,5-bisphosphate and ATP-sensitive potassium channel regulation: a word of caution. Diabetes 49: 1409-1412, 2000.

24.   Li, RA, Leppo M, Miki T, Seino S, and Marban E. Molecular basis of electrocardiographic ST-segment elevation. Circ Res 87: 837-839, 2000.

25.   Mantelli, L, Amerini S, Filippi S, and Ledda F. Blockade of adenosine receptors unmasks a stimulatory effect of ATP on cardiac contractility. Br J Pharmacol 109: 1268-1271, 1993.

26.   Matsubayashi, T, Matsuura H, and Ehara T. On the mechanism of the enhancement of delayed rectifier K+ current by extracellular ATP in guinea-pig ventricular myocytes. Pflügers Arch 437: 635-642, 1999.

27.   Noma, A. ATP-regulated K+ channels in cardiac muscle. Nature 305: 147-148, 1983.

28.   Okamura, M, Kakei M, Ichinari K, Miyamura A, Oketani N, Koriyama N, and Tei C. State-dependent modification of ATP-sensitive K+ channels by phosphatidylinositol 4,5-bisphosphate. Am J Physiol Cell Physiol 280: C303-C308, 2001.

29.   Qu, Y, Campbell DL, and Strauss HC. Modulation of L-type Ca2+ current by extracellular ATP in ferret isolated right ventricular myocytes. J Physiol (Lond) 471: 295-317, 1993.

30.   Shyng, SL, and Nichols CG. Membrane phospholipid control of nucleotide sensitivity of KATP channels. Science 282: 1138-1141, 1998.

31.   Skobel, E, and Kammermeier H. Relation between enzyme release and irreversible cell injury of the heart under the influence of cytoskeleton modulating agents. Biochim Biophys Acta 1362: 128-134, 1997.

32.   Takizawa, T, Hara Y, Saito T, Masuda Y, and Nakaya H. Alpha1-adrenoceptor stimulation partially inhibits ATP-sensitive K+ current in guinea pig ventricular cells: attenuation of the action potential shortening induced by hypoxia and K+ channel openers. J Cardiovasc Pharmacol 28: 799-808, 1996.

33.   Tamaoki, T, Nomoto H, Takahashi I, Kato Y, Morimoto M, and Tomita F. Staurosporine, a potent inhibitor of phospholipid/Ca++ dependent protein kinase. Biochem Biophys Res Commun 135: 397-402, 1986.

34.   Taniguchi, J, Kokubun S, Noma A, and Irisawa H. Spontaneously active cells isolated from the sino-atrial and atrio-ventricular nodes of the rabbit heart. Jpn J Physiol 31: 547-558, 1981.

35.   Tolbert, ME, White AC, Aspry K, Cutts J, and Fain JN. Stimulation by vasopressin and alpha -catecholamines of phosphatidylinositol formation in isolated rat liver parenchymal cells. J Biol Chem 255: 1938-1944, 1980.

36.   Vassort, G, Puceat M, and Alvarez J. Regulation of cardiac activity by ATP, a purine agonist. In: Molecular Physiology and Pharmacology of Cardiac Ion Channels and Transporters, edited by Morad M, Ebashi S, Trautwein W, and Kurachi Y.. Dordrecht, The Netherlands: Kluwer, 1996, p. 231-238.

37.   Willars, GB, Nahorski SR, and Challiss RA. Differential regulation of muscarinic acetylcholine receptor-sensitive polyphosphoinositide pools and consequences for signaling in human neuroblastoma cells. J Biol Chem 273: 5037-5046, 1998.

38.   Wilson, AN, and Broadley KJ. Analysis of the direct and indirect effects of adenosine on atrial and ventricular cardiac muscle. Can J Physiol Pharmacol 67: 294-303, 1989.

39.   Xie, LH, Takano M, Kakei M, Okamura M, and Noma A. Wortmannin, an inhibitor of phosphatidylinositol kinases, blocks the MgATP-dependent recovery of Kir6.2/SUR2A channels. J Physiol (Lond) 514: 655-665, 1999.

40.   Xie, LH, Horie M, and Takano M. Phospholipase C-linked receptors regulate the ATP-sensitive potassium channel by means of phosphatidylinositol 4,5-bisphosphate metabolism. Proc Natl Acad Sci USA 96: 15292-15297, 1999.

41.   Yokoshiki, H, Sunagawa M, Seki T, and Sperelakis N. ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells. Am J Physiol Cell Physiol 274: C25-C37, 1998.


Am J Physiol Heart Circ Physiol 282(2):H757-H765
0363-6135/02 $5.00 Copyright © 2002 the American Physiological Society




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/2/H757    most recent
00246.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oketani, N.
Right arrow Articles by Tei, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oketani, N.
Right arrow Articles by Tei, C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online